Get started
Work

Defining and Managing Suicidal Risk in Patients Taking Psychotropic Medications

Year: 2009
Type: article
Abstract: Article AbstractIn March 2004, the US Food and Drug Administration (FDA) issued a public health advisory warning that antidepressant treatment may increase suicidality and worsen depression in adult and pediatric patients. Then, in May 2007, the FDA proposed that the black box warning in the prescribing information for antidepressants and other drugs used to treat depression be updated to include a warning about an increased risk of suicidality in young adults. In January 2008, the FDA announced that antiepileptic medication labeling will be required to include a warning about an increased risk of suicidality.
DOI: 10.4088/jcp.8145co0c
Institutions: University of Iowa, Harvard University, University of Cape Town, University of New Mexico, McLean Hospital, University of Chicago, Icahn School of Medicine at Mount Sinai
Language: English
Field: Psychology
Open Access status: bronze
Funders: Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Servier, H. Lundbeck A/S, National Institute of Mental Health
OpenAlex ID: W2296591809
FWCI: 2.117
Cites: 37
Cited by: 9
Related to: 10